Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0001451612-25-000008

Director sold 194,932 shares at an average $30.47 ($5,939,784)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Booth Bruce Director 2025-10-10 Sale 10b5-1 −16,727 $29.98 $501,475 2,763,574 I: show line 1 in the form
Booth Bruce Director 2025-10-10 Sale 10b5-1 −3,511 $29.98 $105,260 781,969 I: show line 2 in the form
Booth Bruce Director 2025-10-13 Sale 10b5-1 −44,048 $30.32 $1,335,535 2,719,526 I: show line 3 in the form
Booth Bruce Director 2025-10-13 Sale 10b5-1 −9,245 $30.32 $280,308 772,724 I: show line 4 in the form
Booth Bruce Director 2025-10-13 Sale 10b5-1 −4,082 $31.03 $126,664 2,715,444 I: show line 5 in the form
Booth Bruce Director 2025-10-13 Sale 10b5-1 −857 $31.03 $26,593 771,867 I: show line 6 in the form
Booth Bruce Director 2025-10-14 Sale 10b5-1 −501 $29.95 $15,005 2,714,943 I: show line 7 in the form
Booth Bruce Director 2025-10-14 Sale 10b5-1 −105 $29.95 $3,145 771,762 I: show line 8 in the form
Open-market sales · 194,932 sh · avg $30.47 · $5,939,784
Loading xslF345X05/form4-10152025_101022.xml…